» Articles » PMID: 12396006

Assays for the Functional Activity of the Mannan-binding Lectin Pathway of Complement Activation

Overview
Journal Immunobiology
Publisher Elsevier
Date 2002 Oct 25
PMID 12396006
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Mannan-binding lectin (MBL) activates complement independently of the adaptive, clonal immune system and thus presents an innate anti-microbial defence mechanism. Events in the MBL pathway of complement activation involve the binding of MBL to patterns of carbohydrate structures presented by the surface of micro-organisms. For the activation of complement to occur MBL must be associated with serine proteases (MBL-associated serine proteases, MASPs) in an MBL/MASP complex. When bound to micro-organisms, the MBL complex mediates the activation of C4 and C2, generating the C3 convertase, C4bC2b. The C4/C2 cleaving activity of the MBL complex is shared with the C1 complex of the classical pathway of complement activation. Different assays that allow for determination of the activity of the MBL complex in serum samples have been developed and are discussed in this report. We present data from one such assay (MBL/MASP activity test), which we have found useful for the routine evaluation of clinical samples. In this assay any influence of the classical pathway has been eliminated by using a hypertonic buffer, which inhibits the binding of C1q to immuncomplexes and disrupt the C1 complex, while leaving the function of the MBL complex intact. In parallel we determine the MBL concentration in the sample. As predicted a very high correlation is observed between the results of the two assays.

Citing Articles

Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicentre RCT.

Mistegaard C, Troldborg A, Torgutalp M, Loft A, Thiel S, Muche B Rheumatol Adv Pract. 2025; 9(1):rkaf007.

PMID: 39959130 PMC: 11825385. DOI: 10.1093/rap/rkaf007.


Exploring complement biomarkers in suspected axial spondyloarthritis.

Mistegard C, Troldborg A, Loft A, Thiel S, Spiller L, Protopopov M RMD Open. 2024; 10(2).

PMID: 38749532 PMC: 11328660. DOI: 10.1136/rmdopen-2024-004127.


Respiratory Outcomes at 5-Year Follow-Up in Children with Mannose-Binding Lectin Deficiency: A Retrospective Cohort Study.

Ramphul M, Poghosyan A, Afzal J, McDermott E, Cliffe L, Bhatt J Thorac Res Pract. 2023; 24(2):85-90.

PMID: 37503644 PMC: 10652073. DOI: 10.5152/ThoracResPract.2023.22121.


High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes.

Dorflinger G, Hoyem P, Laugesen E, Ostergaard J, Funck K, Steffensen R Front Immunol. 2023; 13:1080388.

PMID: 36618347 PMC: 9816478. DOI: 10.3389/fimmu.2022.1080388.


Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.

Meziani S, Ferrannini G, Bjerre M, Hansen T, Ritsinger V, Norhammar A Cardiovasc Diabetol. 2022; 21(1):129.

PMID: 35804351 PMC: 9270763. DOI: 10.1186/s12933-022-01562-0.